Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Suspended 1Enrolling by invitation 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 33Breast Neoplasms 25Colorectal Neoplasms 20Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Brain Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Lung Neoplasms 6Colonic Neoplasms 6Pain 5Depression 5Carcinoma, Hepatocellular 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Motor Activity 4Inflammation 4Head and Neck Neoplasms 4Epilepsy 4Dementia 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Lymphoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Cytokine Release Syndrome × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡